PERRIGO Co plc (PRGO) income statement
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3031% below fair value
$15.94−0.10 (-0.62%)
Close on Nov 20, 2026Market cap $2.21BP/E –Yield 7.28%
PERRIGO Co plc financial ratios
See a number that looks wrong?